Immune Thrombocytopenia (ITP) Clinical Trials

A listing of Immune Thrombocytopenia (ITP) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 48 clinical trials
None
Contribution of Anti-platelet Antibodies Identified With MAIPA Assay in the Demonstration of the Auto-immune Character of a Thrombocytopenia at Diagnosis

Immune thrombocytopenia (ITP) is an autoimmune disease but, paradoxically, and unlike other autoimmune diseases, antiplatelet antibodies are not used either for the diagnosis of the disease or

autoimmune disease
monoclonal antibodies
acute leukemia
platelet aggregation
thrombocytopenia
  • 0 views
  • 02 Jun, 2021
  • 1 location
None
Safety and Efficacy of Fecal Microbiota Transplantation

, dysbiotic bowel syndrome, MRSA enteritis, Pseudomembranous enteritis, idiopathic thrombocytopenic purpura (ITP), and atopy. Despite FMT appears to be relatively safe and efficacious in treating a

diabetes mellitus
celiac disease
liver disease
microbiota
antibiotic
  • 313 views
  • 24 Jan, 2021
  • 1 location
None
Eltrombopag Combined With Low-dose Rituximab in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies

This prospective, open-label, nonrandomized, multicenter clinical trial aims at comparing the efficacy and safety of combined use of eltrombopag with low-dose rituximab vs. the best available therapyBATin adult immune thrombocytopenia with autoantibodies fail (due to intolerance or resistance) to first-line treatment.

sjogren's syndrome
lupus
immunosuppressant
danazol
eltrombopag
  • 0 views
  • 14 Jun, 2021
  • 1 location
None
Pilot Trial of Eltrombopag in Patients Undergoing Chemotherapy for Malignant Solid Tumors

Primary Objective: To assess safety of eltrombopag in pediatric patients undergoing intensive chemotherapy for malignant solid tumors. Secondary Objectives: To assess the efficacy of eltrombopag in increasing platelet count up to 2 weeks after completion of chemotherapy in pediatric patients undergoing intensive chemotherapy for malignant solid tumors. Hypothesis: The hypothesis …

  • 0 views
  • 02 Aug, 2021
  • 1 location
None
Eltrombopag With Standard Immunosuppression for Severe Aplastic Anemia

Background Severe aplastic anemia is a rare and serious blood disorder. It happens when the immune system starts to attack the bone marrow cells. This causes the bone marrow to stop making red blood cells, platelets, and white blood cells. Standard treatment for this disease is horse-ATG and cyclosporine, which …

immunosuppression
white blood cells
anemia
neutrophil count
platelet count
  • 114 views
  • 18 Jul, 2021
  • 1 location
None
Post IVIG Medication in Children With Immune Thrombocytopenia

This study is a single hospital system, single-arm year-long pilot to evaluate the feasibility of enrolling children with ITP who are receiving IVIG for treatment of disease to a scheduled post-infusion medication for 72 hours following IVIG infusion. This year-long feasibility pilot will test the (1) feasibility of enrollment and …

treatment regimen
thrombocytopenia
igiv
blood tests
  • 0 views
  • 31 Oct, 2021
  • 1 location
None
Basket Study to Assess Efficacy, Safety and PK of Iptacopan (LNP023) in Autoimmune Benign Hematological Disorders

The main purpose of this study is to evaluate the efficacy and safety of iptacopan in participants with autoimmune benign hematological disorders such as primary immune thrombocytopenia and primary cold agglutinin disease.

thrombocytopenia
hemolysis
anemia
  • 0 views
  • 03 Jan, 2022
  • 4 locations
None
Avatrombopag in the Treatment of Primary Immune Thrombocytopenia(ITP)

The project was undertaking by Qilu Hospital of Shandong University and other well-known hospitals in China. Aims at evaluating effectiveness and safety of avatrombopag in the treatment of primary immune thrombocytopenia.

  • 0 views
  • 10 Jul, 2021
  • 1 location
None
The ITP-RITUX Cohort: Rituximab in Immune ThrombocytoPenia.

The primary purpose of the study is to describe by a prospective observational study the serious adverse events occurring in patients treated off-label by rituximab for Immune Thrombocytopenia.

lupus
thrombocytopenia
autoimmune disease
autoimmune thrombocytopenia
rituximab
  • 240 views
  • 08 Nov, 2020
  • 1 location
None
Autoimmune Cytopenias : Midi-Pyrenees Registry

CARMEN is a clinical registry of all incident adult Immune thrombocytopenia (ITP) and Autoimmune Hemolytic anemia (AIHA) patients in the Midi-Pyrenees region (South of France). It is aimed at

thrombocytopenia
autoimmune thrombocytopenia
cytopenia
anemia
  • 42 views
  • 12 Sep, 2021
  • 2 locations